INSM

2025Q3BMO

Insmed Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-10-30 · Fiscal end 2025-09-30 · Features as of 2025-10-29

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-1.37
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.8%
IV front—
P/C full—
P/C front—
Features as of2025-10-29

Run-up

Close—
Ret 5d+4.1%
Ret 10d+2.1%
Ret 20d+13.4%
Ret 30d+15.3%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-1.75Miss
Estimated EPS-1.37
Actual revenue
142.3M
Surprise %-27.7%
Beat / missMiss
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction+13.4%
Implied vs actual

Implied 2.8%Actual 2.6%

Gap reaction+2.6%
Day result+16.3%
Next-day upYes
Realized / IV0.91×

Post tape

Post 5d-4.4%
Post 10d-1.7%
Post volume6.7M
Vol ×10d3.77×
Vol ×20d3.63×
Post range16.2%